logo

Biotech Stocks Facing FDA Decision In October 2022

1 / 11
Introduction
Introduction

The month of September saw 7 novel drugs secure FDA approval, the highest monthly figure over the last eight years.

So far this year, only 40 novel drugs have been greenlighted (Jan. to Sep.) compared to 40 during the same period last year.